contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls {
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


cell-impact-q3-2024-continued-development-of-the-production-capacity

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

alternatePageUrls

imgUrl

description

Cell Impact is a technology company focused on the industrial sector. The company produces and delivers flow plates and production technology to manufacturers of fuel cells. The company has developed and patented a method for high-velocity forming (adiabatic high-velocity forming) that makes it possible to manufacture flow plates with high energy density. The largest operations are found in the transport sector, with a focus on warehouse vehicles, buses and light trucks, and passenger cars. 

Cell Impact

Cell Impact has significantly reduced its cost base, and the company is ready for high-volume manufacturing.The Group's net sales for the third quarter of 2024 amounted to SEK 5.6 million (9...

<div class="abstract">Cell Impact has significantly reduced its cost base, and the company is ready for high-volume manufacturing.</div>The Group's net sales for the third quarter of 2024 amounted to SEK 5.6 million (9.3), down 40 percent year-on-year.- During the quarter, we continued to deliver in our existing partnerships, with a strong focus on our ability to provide highly specialized services that support our customers in developing high-efficiency flow plates that are adapted to our cost-effective production process, said Daniel Vallin, CEO of Cell Impact.Financing deemed sufficient for 2025The cost-saving programs that were implemented in 2023 have now taken full effect. The cash position declined only about SEK 4 million in the quarter, which is a considerably lower rate of decrease and thus a major improvement compared to previous quarters.- Given the capital contribution that the company received in the recently completed share issue, our current assessment is that the company is sufficiently financed for 2025. This provides us with good prospects to continue developing our operations and our production facility, making us more attractive as a partner and supplier, said Daniel Vallin.Financial summary<ul><li>Net sales totaled SEK 5.6 million (9.3).</li><li>Operating loss (EBIT) was SEK -17.7 million (-23.7).</li><li>The Group's result after financial items was SEK -17.7 million (-24.9).</li><li>Earnings per share attributable to the Parent Company's shareholders before and after dilution totaled SEK -0.03 (-0.33).</li><li>Debt/equity ratio was 84 percent (75) on the balance sheet date.</li><li>Cash flows from operating activities amounted to SEK 0.8 million (-26.3).</li><li>On the balance sheet date, the Group's cash and cash equivalents totaled SEK 18.2 million (35.1).</li><li>On November 5, the company's cash and cash equivalents amounted to SEK 30.9 million.</li></ul>This information is inside information that Cell Impact AB is obliged to make public pursuant to the EU Market Abuse Regulation.

Cell Impact Q3 2024: Continued development of the production capacity

Federal Reserven korkopäätös: Kiire loppui tähän

Lääkekehityssijoittaminen: Arvonluonti yrityskaupoilla ja lisensointisopimuksilla

EKP:n korkopäätös: Keskuspankki ilman rajoitteita

Euroalueen ostopäälliköt: Onks sen jälkeen vielä mäki?

Laskuviikko takana Euroopassa, EKP:n viesti sai lopulta velkakirjakorot nousuun

Pysy ajantasalla Inderesin uutiskirjeillä